Presentation Information

[ISS03-07]Characteristic features and Future approach of Heteroduplex oligonucleotide (HDO) on the Toxicities reduction in Nucleic acid drugs

○Shuichi Toriya1 (1. Rena Therapeutics)

Password required to view


Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.